分析
2026年9月24日•1分で読めます
Oseltamivir Suspension Powder Faces Supply Shortage Amid Rapid Flu Spread in Korea
Pharmacies report stockouts of pediatric oseltamivir suspension powder as influenza cases surge; some manufacturers still hold inventory, but supply pressure is rising.
分析
2026年9月21日•1分で読めます
US Women's Care Market Sees Rise in Clean‑Ingredient Products, Good Clean Love Leads
US consumers are increasingly seeking clean‑ingredient women’s health products; Good Clean Love’s Almost Naked lubricant tops sales.
分析
2026年9月19日•1分で読めます
Pharmacy Inventory Management Critical for Profitability and Cash Flow
Effective control of drug stock, including expiry dates and storage conditions, impacts pharmacy revenue, cash flow, and tax burden.
分析
2026年9月14日•1分で読めます
Hanmi and Dongkook Lead Ibuprofen Cold Medicine Market; Chong Kun Dang and Dong‑A Join Competition This Fall
After the 2025 OTC standard change, Hanmi and Dongkook launched ibuprofen‑combination cold medicines last winter, and this fall Chong Kun Dang and Dong‑A are entering, expanding market competition.
分析
2026年9月8日•1分で読めます
Dongkook Pharmaceutical Launches TECA Plus Formula Facial Repair Cream Light
Dongkook Pharmaceutical’s dermal repair brand Madecaphamacia introduced the TECA Plus Formula Facial Repair Cream Light, featuring enhanced moisture, absorption, and added PDRN, available in ~6,000 Korean pharmacies.
分析
2026年9月7日•1分で読めます
KPA and Paju City Sign MOU to Build Joint Pharma Logistics Hub in Peace Economic Zone
The Korean Pharmaceutical Distribution Association and Paju city have signed an MOU to develop a 100,000‑pyeong pharmaceutical and biotech logistics complex within the Paju Peace Economic Zone.
分析
2026年9月1日•1分で読めます
Samjin Pharma to Normalize HydraSec Supply After MFDS Pediatric Indication Withdrawal
Following MFDS removal of pediatric use for diacetyl hexyl smectite, demand shifted to HydraSec, causing shortages; Samjin Pharma expects supply normalization this week.
分析
2026年8月30日•1分で読めます
Taejeon Group Secures Exclusive Korean Distribution Rights for Metagenics Health Supplements
Taejeon Group has signed an exclusive distribution agreement with US health‑supplement brand Metagenics, aiming to launch its products to Korean pharmacists, healthcare professionals and consumers.
分析
2026年8月26日•1分で読めます
Korea Secures Enrylaze Supply as Alternative to Discontinued Erwinase for ALL & Lymphoma
Following the shutdown of Erwinase’s manufacturer, Korea’s Rare & Essential Medicines Center signed a contract for Enrylaze, restoring treatment continuity for acute lymphoblastic leukemia and lymphoma patients.